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The preparation of 8-amino-3-[(2-hydroxyethoxy)methyl]-1,2,4-
triazolo[4,3-a]pyrazine (IV) as an analogue of 9-[(2-hydroxyeth-
oxy)methyl]guanine and 9-(S)-(2,3-dihydroxypropyl)adenine is de-
scribed from the reaction of 3-chloro-2-hydrazinopyrazine (V) and
ethyl 2-(2-acetoxyethoxy)thioacetimidate (IXg) followed by treat-
ment with ammonia. Compound IV was found to lack antiviral
properties towards herpes simplex I and II, vaccinia virus, vesi-
cular stomatitis virus, measles, reovirus type 1, parainfluenza
virus type 3, Sindbis virus, Coxsackie type B4 virus, and polio-
virus type lo
9-[(2-Hydroxyethoxy)methyl]guanine (I)1 and 9-(S)-(2,3-dihydroxypropyl)-
-adenine (II)lC,2 have been shown to possess inter est ing antiviral activity
and, as a consequence, have provided an impetus for the search for other
biologically active »partial« nucleosides.1C,ld,3 Arising from our studies with
the nucleoside III,4 this paper reports the synthesis and antiviral activity of
8-amino-3-[(2-hydroxyethoxy)methyl]-1,2,4-triazolo[4,3-a]pyrazine (IV) which
incorporates a base unit isomeric to the base unit of II and a side-chain
isomeric to the side-chain of I.
Chemistry
1,2,4-Triazolo[4,3-a]pyrazines are most easily constructed" by reacting
hydrazinopyrazines with ortho esters or thioimidates. Thus, 3-chloro-2-hy-
drazinopyrazine (V)6 was treated with trimethyl ortho(2-chloroethoxy)ace-
tate (VI) to give 8-chloro-3-[(2-chloroethoxy)methyl]-1,2,4-triazolo[4,3-a]pyra-
zine (VII). Ammonolysis of VII produced VIlI but numerous attempts at eon-
verting VIlI into IV were unsuccessful, often giving extremely hygroscopic
products.
Attention then turned to having the side-chain hydroxyl, or a protected
form of it, in place at the time of ring closure with V. This necessitated un-
covering a route to the appropriate nitrile (IXa) for transformation to the
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ortho ester or the thioimidate. In this regard, attempts to displace the chloro
substituent of IXb (prepared from ethylene glycol monomethyl or mono-
benzyl ether and paraformaldehyde in the presence of anhydrous hydrogen
chloride)":" with cyanide ion failed under a variety of conditions." Similar
problems were encountered with efforts to react IXc8 with cyanide and upon
treatment of 1,3-dioxolane with trimethylsilyl cyanide? in hopes of obtaining
IXd.
Success was achieved, however, when 1,3-dioxolane was reacted with
acetyl chloride to give IXe which, following reaction with cuprous cyanide,
was transformed into IXf, The ortho ester derivative of IXf via the Pinner
procedure could not be achieved, As a consequence, the thioimidate IXg
was prepared by reacting IXf with ethanethiol in the presence of anhydrous
hydrogen chloride. Heating IXg with V in pyridine gave 3-[(2-acetoxyethoxy)-
-methyIJ-8-ethylthio-1,2,4-triazolo[4,3-aJpyrazine (X). Conversion of X into
the desired IV was accomplished by heating with ammonia at 127°C for
22 hours (any less reaction time or a lower temperature led to deacetylation
of X without substitution of the ethylthio group at C-8).
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Biological Resuits
Compound IV did not display any antiviral potential against herpes
sim pl ex I, herpes simplex II, vaccinia virus and vesicular stomatitis virus,
measles, reovirus type 1, parainfluenza virus type 3, Sindbis virus, Cox-
sackie type B4 virus and poliovirus type 1 as evidenced by a minimum
inhibitory concentration-? of 200 ug/ml, or greater.'!
EXPERIMENTAL
General Methods
All melting points were obtained on a Thomas-Hoover or a Mel-Temp melting
point apparatus and are uncorrected. Infrared spectra were recorded on a Beckman
AccuLab 3 spectrophotometer. The IH NMR spectra were determined at 60 MHz
with a Varian EM-360 spectrometer and are reported in parts per million down-
field from tetramethylsilane as an internal standard. The spin multiplicities are
indicated by the symbols s (singlet), d (doublet), t (triplet), m (multiplet), and br
(broad). The silica gel used for the separation was Baker 60-200 mesh. Elemental
analyses were performed by M-H-W Laboratories, Phoenix, Arizona.
8-Chloro-3-[( 2-chloroethoxy )methy lJ-l ,2,4- triazolo[ 4,3-aJpyrazine (VII)
Paraformaldehyde (44.8 g) and 2-chloroethanol (100 mL, 120.1 s. 1.49 mol) were
cooled in an ice bath. Anhydrous hydrogen chloride was bubbled into the solution
for 1.5 h. The organic and aqueous layers were separated, and the organic layer
dried over calcium chloride. The organic portion was concentrated by distillation
under a stream of dry nitrogen and to the residue was added a mixture of dry
cuprous cyanide (150 g, 1.67 mol) in dry benzene (600 mL). This mixture was
refluxed for 5 h, filtered, and the benzene removed by evaporation. The dark
residue was vacuum distilled through a 10-inch Vigreux column and the second
fraction (b. p. 95-97 °C/1 mm) was collected to give 59.31 g (0.496 mol, 33%)
of 2-(2-chloroethoxy)acetonitrile: IH "N"MR(neat) c5 3.74 (m, 4 H, CH2CH2), 4.3 (s,
2H. OCH2CN).
Anhydrous hydrogen chloride was next bubbled into a solution of dried
methanol (5.6 mL), 2-(2-chloroethoxy)acetonitrile (14 g, 0.117 mol), and dry diethyl
ether (40 mL) for 15 min und er ice water cooling. This mixture was placed in a
freezer for one day and the liquid removed by decantation. The solid remaining
was washed with anhydrous diethyl ether and the ether removed by evaporation.
Dry methanol (50 mL) was added to the residue and the solution allowed to
stand for one day. The methanol was removed by evaporation and anhydrous
diethyl ether added. This mixture was filtered to remove the ammonium chloride,
and anhydrous potassium carbonate and molecular sieves (3 A) were added to
the filtrate. After three days, this mixture was filtered and the ether again
removed by evaporation. Petroleum ether was added to the residue. The amide
by-product was removed by filtration, and the petroleum ether evaporated to give
8.25 g (0.042 mol, 36%) of trimethyl ortho(2-chloroethoxy)acetate (VI) as a clear,
colorless liquid of sufficient purity for use in the next step: iH NMR (neat) c5 3.2~
(s, 9 H, OCH3), 3.69 (m, 4 H, CH2CH2), 4.12 (s, 2 H, CH2).
A mixture of VI (15 g, 75.5 mmol) and V6 (2.5 g, 17.29 mmol) was refluxed
in dry xylene (20 mL) for 3 h. Hexane was added to the solution and the resulting
precipitate isolated by filtration. The crude solid (2.6 g) was purified by recrystal-
lization from methylene chloride/pentane (charcoal) to give 2.14 g (8.66 mmol, 50%)
of VII as yellow plates: m. p. 113-115°C; IR (KBr) 1610 (C=C) cm-I; IH NMR
(CDC13) c5 3.7 (m, 4 H, CH2CH2), 5.12 (s, 2 H, CH2), 7.7 (d, J = 5 Hz, 1 H, H-6),
8.29 (d, J = 5 Hz, 1 H, H-5).
AnaL. CsHsChN40 (247.08) Calc'd.: C 38.89; H 3.26; N 22.68%
Found: C 38.89; H 3.26; N 22.54%
8-A mino-3 -[(2-chloroethoxy )meth y lJ-l ,2,4- triazolo[ 4,3-aJpyrazine (VIlI)
A mixture of VII (1.56 g, 6.31 mmol) in 70 mL of ethan al containing 20 mL
of anhydrous ammonia was heated at 700C for 24 h in a stainless steel sealed
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reaction vessel. After cooling, the vessel was opened, and the solid obtained by
filtration and washed with ethanol and 2-propanol to give 0.78 g of a pale yellow
solid. The solid was recrystallized twice from water (charcoal) to give 0.25 g of
a white solid which, following recrystallization from ž-propanol, gave 0.22 g
(0.996 mmol, 15.3%) of VIlI as white crystals: m. p. 190-191°C; IR (KBr) 3280
(NH2) cm+; 1H NMR (DMSO-d6) b 3.73 (s, 4 H, CH2CH2), 5.0 (s, 2 H, CH2), 7.25
(d, J = 5 Hz, '1 H, H-6), 7.44 (br, 2 H, NH2), 7.68 (d, J = 5 Hz, 1 H, H-5).
AnaL. CSH10ClNsO (227.65) Calc'd.: C 42.21; H 4.43; N 30.76%
Found: C 42.14; H 4.31; N 31.00%
8-Eth y 1thio-S» [(2-acetoxyethoxy )meth y 1]-1,2,4- triazoto] 4,3 -a]pyrazine (X)
Acetyl chloride (44 mL, 48.58 g, 0.619 mol) was added to a mixture of 1,3-di-
oxolane (48 mL, 50.88 g, 0.687 mol) and dry methanol (0.9 mL, 0.72 g, 0.022 mol).
The resultant solution was allowed to stand at room temperature for 10 days. It
was then added dropwise into a refluxing mixture of cuprous cyanide (80 g, 0.893
mol) in dry benzene (300 mL). The mixture was then refluxed for 7 h and eon-
centra ted under reduced pressure to 62.96 g (0.44 mol, 71%) of IXf as a clear
colorless liquid which was used directly in the next step: 1H NMR (neat) b 2.01
(s, 3 H, CH3), 3.74 (t, J = 6 Hz, 2 H, OCH2), 4.2 (t, J = 6 Hz, 2 H, OCH2), 4.;)4
(s, 2 H, OCH2CN).
To an ice chilled mixture of IXf (10 mL, 10.24 g, 72 mmol) in ethanethiol
(5.1 mL, 4.28 g, 70 mmol) and dry diethyl ether (90 mL) was added anhydrous
hydrogen chloride over a period of 15 min. This mixture was placed in a freezer
overnight and the n evaporated, under vacuum, to an oil, assumed to be IXg. Dry
pyridine (100 mL) and V (6 g, 41.5 mm 01) were added to' the oil and the mixture
stirred for 6 h at room temperature. The mixture was then filtered, and the
solids obtained were washed with pyridine and methylene chloride. The filtrate
was evaporated to a black residue and the residue was dissolved in methylene
chloride, treated with charcoal, and filtered. The dark filtrate was placed on a
silica gel column and found to give a dark oil after eluting with methylene
chloride-acetone (9: 1). The oil crystallized on standing to give 6.35 g of a brown
material which was dissolved in hot toluene, treated with charcoal, filtered hot,
cooled to room temperature, and treated with hexane which caused precipitation.
The resultant precipitate was isolated by filtration and recrystallized from aqueous
methanol to give 4.05 g (13.7 mmol, 33%) of X as white crystals: m. p. 102-103°C;
IR (KBr) 1700 (C=O) cm": 1H NMR (CDC13) (; 1.45 (t, J = 6 Hz, 3 H, CH3 of
ethylthio), 2.03 (s, 3 H, CH3 of acetate), 3.35 (q, J = 6 Hz, 2 H, CH2 of ethylthio),
3.76 (m, 2 H, OCH2 of ethoxy), 4.21 (m, 2 H, OCH2 of ethoxy), 5.12 (s, 2 H, isolated
CH2 of C-3 side-chain), 7.68 (d, J = 5 Hz, 1 H, H-6), 7.9 (d, J = 5 Hz, 1 H, H-5).
AnaL. C12HJ6N403S (296.35) Calc'd.: C 48.64; H 5.44; N 18.91%
Found: C 48.44; H 5.61; N 18.89%
8-Amino-3-[(2-hydroxyethoxy)methyl]-1,2,4-triazo1o[4,3-a]pyrazine (IV)
Ethanol (35 mL), liquid ammonia (15 mL), and X (1.05 g, 3.54 mmol) were
heated together in a 100 mL stainless steel sealed reaction vessel for 32 h at
127°C. After cooling the vessel, the solvents were evaporated under vaccum to
give 0.52 g of a tan powder. Recrystallization of this powder from ethyl acetate
gave 0.42 g (2 mmol, 56.5%) of IVas pink crystals. After three recrystallizations
from ethyl acetate, IV was obtained as white needles: m. p. 152-153°C; IR (KBr)
3250 (OH) cm"; 1H NMR (DMSO-d6) b 3.53 (s, 4 H, CH2CH2), 4.63 (br, 1 H, OH),
4.98 (s, 2 H, CH2), 7.36 (br, 3 H, H-6 and NH2), 7.7 (d, 1 H, J = 5 Hz, H-5).
AnaL. C8HUNs02 (209.208) Calc'd.: C 45.93; H 5.30; N 33.48%
Found: C 46.03; H 5.18; N 33.71%
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POVZETEK
Sinteza in antivirusne lastnosti 8-amino-3-!(2-hidroksietoksi)
metili -1,2,4-triazoJo -/4,3 -alpirazola
S. W. Schneller, J. L. May in E. De Clercq
Opisali smo sin tezo 8-amino-3-/ (2-hidroksietoksi)metil/ -1,2,4- triazolo/4,3-a/pira-
zina (IV) kot analoga 9-/(2-hidroksietoksi)metil/guanina in 9-(S)-(2,3-dihidroksipro-
pil)adenina iz 3-kloro-2-hidrazinopirazina (V) in etil 2-(2-aeetoksietoksi) tioaeetamida
(IXg) in sledečo reakcijo z amoniakom. Spojina IV ne kaže antivirusne aktivnosti
proti herpes simplex I in II, vaecinia virusu in virusu stomatitisa.
